Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milena Cannella

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Journal of the Neurological Sciences|December 9, 2008
Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene: Huntington disease or phenocopy?Yuval O Herishanu, Ruti Parvari, Yaakov Pollack, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 13, 2009
Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophinsFerdinando Squitieri, Sara Orobello, Milena Cannella, et al.
Current Neuropharmacology|June 3, 2025
Sex-Dependent Modulation of AMPA and GABA<sub>A</sub> Receptors in Response to Perinatal Stress: Implications for Cognitive and Emotion-related BehaviorsAlessandra Gaetano, Vance Gao, Gilles Van Camp, et al.
Molecular Pain|October 24, 2012
N-Acetyl-cysteine causes analgesia by reinforcing the endogenous activation of type-2 metabotropic glutamate receptorsMatteo Bernabucci, Serena Notartomaso, Cristina Zappulla, et al.
Human Molecular Genetics|September 4, 2003
The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexesMaria G Macedo, Burcu Anar, Iraad F Bronner, et al.
CNS Neuroscience & Therapeutics|February 21, 2009
Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's diseaseFerdinando Squitieri, Milena Cannella, Maria Simonelli, et al.
Journal of Neurochemistry|August 10, 2006
Genotype-dependent priming to self- and xeno-cannibalism in heterozygous and homozygous lymphoblasts from patients with Huntington's diseaseElisabetta Mormone, Paola Matarrese, Antonella Tinari, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 3, 2004
The gender effect in juvenile Huntington disease patients of Italian originMilena Cannella, Cinzia Gellera, Vittorio Maglione, et al.
Current Neuropharmacology|July 1, 2026
Effects of Drugs for the Treatment of Multiple Sclerosis in Severe Acute Respiratory Syndrome Coronavirus 2 Infection on the Expression of Angiotensin-converting Enzyme 2 in vitroRoxana P Ginerete, Tiziana Imbriglio, Marika Alborghetti, et al.
Molecular Pain|March 23, 2017
Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic painSerena Notartomaso, Giada Mascio, Matteo Bernabucci, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Journal of the Neurological Sciences|December 9, 2008
Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene: Huntington disease or phenocopy?Yuval O Herishanu, Ruti Parvari, Yaakov Pollack, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 13, 2009
Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophinsFerdinando Squitieri, Sara Orobello, Milena Cannella, et al.
Current Neuropharmacology|June 3, 2025
Sex-Dependent Modulation of AMPA and GABA<sub>A</sub> Receptors in Response to Perinatal Stress: Implications for Cognitive and Emotion-related BehaviorsAlessandra Gaetano, Vance Gao, Gilles Van Camp, et al.
Molecular Pain|October 24, 2012
N-Acetyl-cysteine causes analgesia by reinforcing the endogenous activation of type-2 metabotropic glutamate receptorsMatteo Bernabucci, Serena Notartomaso, Cristina Zappulla, et al.
Human Molecular Genetics|September 4, 2003
The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexesMaria G Macedo, Burcu Anar, Iraad F Bronner, et al.
CNS Neuroscience & Therapeutics|February 21, 2009
Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's diseaseFerdinando Squitieri, Milena Cannella, Maria Simonelli, et al.
Journal of Neurochemistry|August 10, 2006
Genotype-dependent priming to self- and xeno-cannibalism in heterozygous and homozygous lymphoblasts from patients with Huntington's diseaseElisabetta Mormone, Paola Matarrese, Antonella Tinari, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 3, 2004
The gender effect in juvenile Huntington disease patients of Italian originMilena Cannella, Cinzia Gellera, Vittorio Maglione, et al.
Current Neuropharmacology|July 1, 2026
Effects of Drugs for the Treatment of Multiple Sclerosis in Severe Acute Respiratory Syndrome Coronavirus 2 Infection on the Expression of Angiotensin-converting Enzyme 2 in vitroRoxana P Ginerete, Tiziana Imbriglio, Marika Alborghetti, et al.
Molecular Pain|March 23, 2017
Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic painSerena Notartomaso, Giada Mascio, Matteo Bernabucci, et al.
Pageof 6